Latest news with #GetScreened
Business Wire
3 days ago
- Health
- Business Wire
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
SAN FRANCISCO--(BUSINESS WIRE)--The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision oncology company focused on improving access to cancer screening and advancing health equity. This collaboration supports ACS's nationwide cancer screening efforts, including the I Love You, Get Screened public awareness campaign; community-based health system partnerships; and state coalition work aimed at removing barriers to lifesaving screenings. ACS and Guardant Health aim to increase awareness, promote early detection, and improve outcomes for individuals in communities that have historically experienced limited access to preventive care. 'Regular cancer screening saves lives by finding certain cancers early, when they are often easier to treat or even prevent altogether,' said Maria Olson, Executive Vice President, American Cancer Society. 'With support from Guardant Health, we can reach more people across the Bay Area with the information, tools, and services they need to take action for their health.' Despite being a hub of healthcare innovation, California continues to fall behind the national average in key cancer screening rates. Data from the American Cancer Society shows that only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally. Colorectal cancer screening rates are also lower, with 60% of eligible Californians screened compared to 62% nationwide. These gaps represent a critical opportunity to expand access and close the screening disparity. In 2025, an estimated 2,041,910 people in the U.S. will be diagnosed with cancer, and more than 600,000 lives are expected to be lost due to cancer. However, due to reductions in smoking and advances in early detection and treatment, cancer mortality has dropped 34% from 1991 to 2022, averting approximately 4.5 million deaths during that time. This work aims to accelerate that momentum, with a special focus on communities that remain underserved. Guardant Health will support the following ACS initiatives: Expanding the reach of the I Love You, Get Screened campaign, which garnered over 313 million impressions in 2024 and delivers culturally relevant education to communities including Black/African American, Hispanic/Latino, and LGBTQ+ populations. Promoting digital tools on including a locator tool that helps individuals find more than 15,000 screening locations across the U.S. Supporting community health interventions, such as patient education, navigation to screening appointments, transportation support, and language access services. These efforts contributed to over 555,000 completed screenings and 7,800 cancers detected in 2024. Collaborating with state coalitions, including those in California, to implement localized strategies that help increase screening rates and reduce disparities. 'Guardant Health is proud to partner with the American Cancer Society in the fight to expand cancer screening access,' said AmirAli Talasaz, Guardant Health co-founder and co-CEO. 'We share a commitment to ensuring that everyone, regardless of race, ethnicity, income, or ZIP code, has access to convenient and timely cancer screening, so we can detect cancer earlier and give them the opportunity for a better outcome.' Throughout 2025, ACS will engage communities across the nation through impactful campaigns aligned with key cancer awareness months—including cervical cancer awareness in January, colorectal in March, prostate in September, breast in October, and lung in November. These efforts will feature personal stories, local events, and trusted education to empower more people to get screened and take charge of their health. To learn more about ACS screening tools or to find a local screening center, visit About the American Cancer Society The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram. About Guardant Health Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit and follow the company on LinkedIn, X (Twitter) and Facebook.
Forbes
14-04-2025
- Health
- Forbes
Screening Saves Lives: Working Together To Promote Early Cancer Detection
By Christina Hernandez Sherwood Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more likely to be successful. That's why the American Cancer Society (ACS) strongly advocates for early detection and works with corporate partners to amplify this message. For example, when the rate of cancer screening tests dropped during the pandemic, the American Cancer Society launched the Get Screened campaign with founding partner Genentech to promote screening resources and recommendations. In 2023, the campaign was renamed I Love You Get ScreenedTM, and while rates have somewhat rebounded, there are still large portions of the screening-age population that are not up to date. Laura Makaroff To address this ongoing issue, ACS recently introduced the cancer risk assessment tool ACS CancerRisk360TM with support from Pfizer to help people understand their risk factors, such as family history and lifestyle, and take action to address them. Corporate partnerships that cross sectors and disciplines bring diverse expertise, resources and innovations to accelerate progress against cancer, said Laura Makaroff, DO, senior vice president of cancer prevention at the American Cancer Society. 'Cancer is a complex public health challenge that requires collaborative solutions,' Makaroff said. 'Partnerships are essential to ACS' efforts in prevention and early detection.' Here's how the American Cancer Society has collaborated with three corporate partners to get millions of people screened for cancer. For more than 40 years, the American Cancer Society and biotechnology company Genentech, a member of the Roche Group, have worked together to improve cancer outcomes. After serving as a founding sponsor of the Get Screened campaign, Genentech again worked alongside ACS in 2023 on the national education campaign Cancer Screen Week. This initiative supported cancer screening efforts in Chicago's Bronzeville neighborhood and the Love Letters For Cancer Screening awareness program that focused on Black and Latina women. The organizations expanded their work together in 2024 and 2025 with cancer screening and navigation pilots in Georgia, Ohio and Oregon designed to address barriers to cancer care related to transportation, food and housing. These initiatives have led to more than 1.4 million cancer screening tests and some 18,000 cancer diagnoses. Levi Garraway 'Screening is an integral part of the fight against cancer,' said Levi Garraway, head of global product development and chief medical officer at Roche and Genentech. 'We have worked hard to expand access to cancer screening for everyone, including populations that may encounter barriers to sufficient health care. Our commitment to provide more accessible cancer care remains strong, yet we recognize there is more work ahead as we continue to improve health outcomes for all people impacted by cancer.' The American Cancer Society named Pfizer its 2024 Corporate Partner of the Year, reflecting the organizations' joint efforts over several years to improve access to cancer screening and quality care. Tina Deignan One such initiative launched last year, Change the Odds: Uniting to Improve Cancer Outcomes, is a three-year American Cancer Society effort sponsored by Pfizer that is designed to improve health outcomes in underserved communities. It aims to do this by enhancing awareness of and access to cancer screenings, clinical trial opportunities, and patient support and comprehensive navigation. Change the Odds is initially focusing on breast and prostate cancers with the potential to expand to other types. 'Breakthrough medicines can't save lives if they can't reach the patients who need them,' said Tina Deignan, commercial president of Pfizer Oncology. 'Through our longstanding efforts with the American Cancer Society, we are working to address barriers to screening and treatment so everyone impacted by cancer can receive the care they deserve.' The American Cancer Society expanded funding for lung cancer screening in 2024 with support from Merck and other partners. Lung cancer, the second most commonly diagnosed cancer in the U.S. — and the most common cause of cancer death — disproportionately affects people with lower socioeconomic status. Linda Kollmar Merck is one of the partners supporting the Get Screened campaign. This effort promotes lung cancer screening in communities with historical inequities through mobile screening, community outreach and patient navigation. It aims to reach up to 10,000 additional eligible individuals. 'Our company aligns with the ACS mission to address high disparities in cancer care,' said Linda Kollmar, associate vice president of patient innovation and engagement value and implementation at Merck Research Laboratories. 'It's critical that we understand, respect and honor the life experiences of patient communities.' Partnerships help the American Cancer Society move its mission forward by breaking down barriers for people along the cancer continuum, Makaroff said. 'These meaningful collaborations inspire the necessary action and enable critical resources to make advancements in prevention, early detection and the treatment of cancer, ultimately changing and saving more lives.' To Learn About All Valued Partners And How Your Organization Can Become One, Visit
